Neuropharmacology Conferences 2018 | Euro Neuropharmacology Conferences 2018 | Pharmacology Meetings | Euro Neuropharmacology Congress | Neurology events | Neurological disorders meetings | Neuropharmacology Summit | Neuropharmacology Conferences Paris | Neuropharmacology Conferences in 2018 France | Europe

Theme: Neuropharmacology: New Revolution, Innovations and Major Challenges

Euro Neuropharmacology 2018

Euro Neuropharmacology 2018

Conference Series llc Ltd is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth "10^th World Congress on Neuropharmacology” (Euro Neuropharmacology 2018) scheduled to be held during August 28-29, 2018 Paris, France

The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmacology and Neuropharmacology.

Why to attend???

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuropharmacology are hallmarks of this conference.

Target Audience:

Neuropharmacology Students, Scientists
Neuropharmacology Researchers
Neuropharmacology Faculty
Medical Colleges
Neuropharmacology Associations and Societies
Business Entrepreneurs
Training Institutes
Software developing companies
Manufacturing Medical Devices Companies
Data Management Companies

2018 Highlights:

300+ Participation (70 Industry: 30 Academia)
5+ Keynote Speakers
50+ Plenary Speakers
20+ Exhibitors
14 Innovative Educational Sessions
5+ Workshops
B2B Meetings

Track 1: Neuropharmacology

Neuropharmacology is the branch of pharmacology which deals with the action of drugs in the nervous system. Behavioral Neuropharmacology and Molecular neuropharmacology are the branches of neuropharmacology. Behavioral neuropharmacology is the study about how drugs affect human behavior (neuropsychopharmacology), and addiction affect human brain. Molecular neuropharmacology involves the study of neurons and their neurochemical Interactions. Behavioral and Molecular fields are very closely connected, since both are concerned with the interactions. In neuropharmacology we also study about the drugs and their targets that influence the functions of the nervous system (brain, spinal cord and peripheral nerves) in health and disease.

3rd International Conference on Dual Diagnosis & Addiction Therapy, June 14-16, 2018 Amsterdam, Netherlands; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Neuroscience and Neuro Chemistry, February 27-28, 2017 Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology March 17-20, 2016 Lisbon, Portugal

Related Societies:

European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 2: Neurology

It is the science in which medicines are used to deal with disorders of the nervous system. Specializing Physicians in the field of neurology are known as neurologists and they are trained to diagnose, treat, and manage patients with neurological disorders. Neurologists are trained to treat and diagnose adults and they are also involved in clinical research and clinical trials. Neurological disorders are ailments that affect the central nervous system (brain, brainstem and cerebellum), the peripheral nervous system (peripheral nerves - cranial nerves included), or the autonomic nervous system.

14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology, March 17-20, 2016, Lisbon, Portugal; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 6th International Conference on Vascular Dementia ,February 27th - March 01st, 2017 Amsterdam, Netherlands

Track 3: Pediatric Neurology

Pediatric Neurology is the branch of medicine that involves the medical care of infants, children, and adolescents. A medical doctor who specializes in this area is known as a pediatrician, or pediatrician. Pediatricians work both in hospitals, particularly those working in its subspecialties such as neonatology, and as primary care physicians.

6th International Conference on Vascular Dementia February 27th - March 01st, 2017 Amsterdam, Netherlands; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology March 17-20, 2016 Lisbon, Portugal. 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, Netherlands

Track 4: Neurobiochemistry

It is the branch of science which is concerned with the study of neurochemicals, including neurotransmitters and other molecules such as psychopharmaceuticals and neuropeptides that influence the function of neurons. Neurobiochemistry is establish with a vision of assisting neurophysicians, neurosurgeons and other health care professionals to provide the best possible diagnosis of their patient’s disorders. The department is playing a key role in development of the super specialty in Neuroscience and provides the facility for patient care by performing many diagnostic tests, and keeps on looking to add on the latest ones. This field within neuroscience examines how neurochemicals influence the operation of neurons, synapses, and neural networks.

7th International Conference on Brain and Neurological Disorders ,Apr 10-12, 2018 Amsterdam, Netherlands ;18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 6th International Conference on Vascular Dementia , February 27th - March 01st, 2017 Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology, March 17-20, 2016 Lisbon, Portugal.

Track 5: Nursing and Neuroscience

Nursing and Neuroscience both are consider within neuropharmacology. Health care sector focused on the care of individuals, families, and communities which are consider within nursing profession. Neuroscience or neurobiology is the scientific study of the nervous system with multidisciplinary branch of biology, which deals with the anatomy, biochemistry, molecular biology, and physiology of neurons and neural circuits. Neuroscience nurses also work with patients suffering from strokes and birth defects that have affected the nervous system. Neuroscience nursing is a profession that helps patients suffering from neurological problems. This field of medicine focuses on the health of the nervous system, including the brain and spinal cord.

6th International Conference on Vascular Dementia, February 27th - March 01st, 2017 Amsterdam, Netherlands; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology, March 17-20, 2016 Lisbon, Portugal. 10th International Conference on Neuroscience and Neuro Chemistry, February 27-28, 2017 Amsterdam, Netherlands

Related Societies:

National Association of School Nurses, European Federation for Pharmaceutical Sciences (EUFEPS), Nurse Practitioner Healthcare Foundation, American Association of Nurse Practitioners, Turkish Pharmacists Association, National Association of Disease Management & Wellness Professionals, American Association of Managed Care Nurses, Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), American Association of Occupational Health Nurses

Track 6: Neural Stem Cells

It deals with the cells which are capable to self-renewing and to proliferate without any limit, to produce progeny cells which terminally differentiate into neurons, astrocytes and oligodendrocytes. Stem cells are characterized by their capacity to differentiate into multiple cell types. They undergo symmetric or asymmetric cell division into two daughter cells. In symmetric cell division, both daughter cells are also stem cells. In asymmetric division, stem cell produces one stem cell and one specialized cell. The non-stem cell progeny of NSCs are referred to as neural progenitor cells. Some neural stem cells persist in the adult vertebrate brain and continue to produce neurons throughout life. NSCs primarily differentiate into neurons, astrocytes, and oligodendrocytes. Neural stem cell, largely undifferentiated cell originating in the central nervous system. Neural stem cells (NSCs) have the potential to give rise to offspring cells that grow and differentiate into neurons and glial cells (non-neuronal cells that insulate neurons and enhance the speed at which neurons send signals).

7th International Conference on Brain and Neurological Disorders, Apr 10-12, 2018 Amsterdam, Netherlands ;18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 6th International Conference on Vascular Dementia ,February 27th - March 01st, 2017 Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology, March 17-20, 2016 Lisbon, Portugal

Related Societies:

European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF),European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association,Turkish Pharmacists Association, Utah Pharmaceutical Association, Maryland Pharmacists Association, Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC)

Track 7: Neuro- AIDS

Neuro-AIDS refers to any neurologic condition occurring as a result of HIV infection. The Mount Sinai Neuro-AIDS Program provides compassionate, comprehensive care to HIV-positive patients with neurological disorders. These conditions include dementia, neuropathy, brain infections, and disorders of the spinal cord and muscle. HIV can affect any part of the nervous system, such as the brain, spinal cord, nerves, or muscle. Depending on which part is involved, symptoms of neurologic disease in HIV-infected individuals may include memory loss, headache, dizziness, weakness, numbness, pain, vision changes, or trouble walking. Primary central nervous system lymphoma (PCNSL), occur only in patients with advanced AIDS. Other neurologic conditions, such as HIV-associated neuropathy and HIV-associated dementia, occur even in patients with well-controlled HIV.

14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology, March 17-20, 2016 Lisbon, Portugal; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 6th International Conference on Vascular Dementia ,February 27th - March 01st, 2017 Amsterdam, Netherlands

Related Societies:

Swedish Neurological Society, World Federation of Neurology, Finnish Neurological Association, Georgian Society of Neurologists, Turkish Pharmacists Association, German Society of Neurology, Italian Society for Pharmaceutical Sciences (SISF), European Academy of Neurology, Utah Pharmaceutical Association, European Behavioural Pharmacology Society (EBPS), Italian Society of Neurology, Maryland Pharmacists Association, European Paediatric Neurology Society, Slovak Neurological Society

Track 8: Neurovirology

Neurovirology is the scientific study of viruses capable of infecting the nervous system. It incorporates the related fields of virology, neuroscience, neurology, immunology, and molecular biology. Neurovirology fields main focus on the study of viruses’ capability of infecting the nervous system and to eliminate detrimental populations of neural cells and the studies of the use of viruses to trace neuroanatomical pathways, for gene therapy. It is Study of viruses which directly infect nerves.

Related Societies:

Italian Society for Pharmaceutical Sciences (SISF),European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association,Turkish Pharmacists Association, Utah Pharmaceutical Association, Maryland Pharmacists Association, Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC),European Federation for Pharmaceutical Sciences (EUFEPS)

Track 9: Neurosurgery

Neurosurgery is the branch of neuroscience in which surgery are performed on the nervous system, especially the brain and spinal cord. It is the medical specialty with the prevention, diagnosis, surgical treatment and rehabilitation of disorders which affect any portion of the nervous system including the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system.

Related Societies:

Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association., European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF)

Track 10: Neuroradiology

Neuroradiology is the subdivision of radiology that deals with the nervous system. It is the subspeciality of radiology which is converging on the diagnosis and characterization of abnormalities of the central and peripheral nervous system, spine, and head and neck using neuroimaging techniques. X-rays is used in the diagnosis and treatment of nervous system disorders. Primary imaging modalities include Computed tomography (CT) and Magnetic resonance imaging (MRI). Ultrasound and Plain radiography is used on a limited basis and in limited circumstances, individual in pediatric population. Probably, Angiography is used for identification of vascular abnormalities or finding and characterization of masses or other lesions but now it is being substituted in many instances like CT or MRI angiography and imaging.

Related Societies:

The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association,Turkish Pharmacists Association, Utah Pharmaceutical Association, Maryland Pharmacists Association, European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF),European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences, Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC)

Track 11: Clinical Neuropharmacology

Clinical Neuropharmacology includes mechanisms of action, structure-activity relationships, and drug metabolism and pharmacokinetics, to practical clinical problems such as drug interactions, drug toxicity, and therapy for specific syndromes and symptomsis.Clinical Neuropharmacology is a branch of science in which we studied about the features, properties, responses and uses of drugs mainly their therapeutic effect in humans along with toxicology, pharmacodynamics and pharmacokinetics.

Related Societies:

Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association, European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS)

Track 12: Molecular Neuropharmacology

Molecular Neuropharmacology is a branch of pharmacology which is concerned with the biochemical mechanisms that mechanisms are responsible for the actions of drugs. It is a program that focuses on the scientific study of the biochemical and biophysical characteristics of drugs at the molecular level and their interaction with, and effects on, biological macromolecules and cellular structures and processes. It is a peer-reviewed scientific journal published by the American Society for Pharmacology and Experimental Therapeutics.

21st World Congress on Controversies in Neurology, March 17-20, 2016 Lisbon, Portugal; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 7th International Conference on Brain and Neurological Disorders, Apr 10-12, 2018 Amsterdam, Netherlands; 8th European Neurology Congress , September , 21- 23, 2019 Amsterdam, Netherlands

Related Societies:

Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association,European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association

Track 13: Biochemical Neuropharmacology

Biochemical Neuropharmacology is concerned with the effects of drugs on biochemical pathways underlying the pharmacokinetic and pharmacodynamic processes and the subsequent therapeutic and the toxicological processes Biochemical pharmacology is the study of the branch of medicine and biology concerned with the study of drug action and the pharmaceutical process is, however, outside the realms of biochemical pharmacology.

Related Societies:

Track 14: Behavioral Neurology

Behavioral Neurology is the study of drug dependence and how drug addiction affects the human mind, Anxiety and Autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus accumbens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatment.

4th Global Experts Meeting on Parkinson’s & Movement Disorders, May 17-18, 2018 Singapore City, Singapore; 7th International Conference on Brain and Neurological Disorders, Apr 10-12, 2018 Amsterdam, Netherlands ; 8th Global Experts Meeting on Advances in Neurology and Neuropsychiatry, August 27-28, 2018 Tokyo, Japan; 12th Global Neurologists Annual Meeting on Neurology and Neuro Surgery, May 17-18, 2018 Singapore City, Singapore

Related Societies:

Swedish Neurological Society, Finnish Neurological Association, Georgian Society of Neurologists, Italian Society for Pharmaceutical Sciences (SISF), Slovak Neurological Society, Italian Society of Neurology, World Federation of Neurology, Turkish Pharmacists Association, German Society of Neurology, Maryland Pharmacists Association, European Academy of Neurology, Utah Pharmaceutical Association, European Behavioural Pharmacology Society (EBPS), European Paediatric Neurology Society

Track 15: Psychopharmacology and Immunopharmacology

Psychopharmacology is the branch of psychology hesitant with the effects of drugs on the mind and behaviour. It is the scientific study of the effects drugs have on mood, sensation, thinking and behavior. It is notable from neuropsychopharmacology, which stresses the association between drug-induced changes in the functioning of cells in the nervous system and changes in realization and behavior. The term "psychopharmacology" was probably first coined by David Macht in 1920.The field of psychopharmacology studies a wide range of substances with various types of psychoactive properties, focusing primarily on the chemical interactions with the brain.

Immunology is the term which is related to immunity is well-defined as that fragment of pharmacology that compacts with drugs acting on the immune system and, in accumulation, with the pharmacological actions of substances imitative from the immune system. It is a subdivision of biology that covers the study of immune systems in all organisms. Applications of Immunology have used in abundant disciplines of medicine, particularly in the fields of organ transplantation, oncology, virology, bacteriology, parasitology, psychiatry, and dermatology.

14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology, March 17-20, 2016 Lisbon, Portugal; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 6th International Conference on Vascular Dementia February 27th - March 01st, 2017 Amsterdam, Netherlands

Related Societies:

Turkish Pharmacists Association, Utah Pharmaceutical Association, Maryland Pharmacists Association, European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF),European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC)

Track 14: Neurological disorders

Neurological disorders are a disorder of the nervous system. It may be Structural, biochemical or electrical abnormalities in the brain, spinal cord or other nerves can result in a range of symptoms. Some other neurological disorders are such as Paralysis, muscle weakness, poor coordination, and loss of sensation, seizures, confusion, pain and altered levels of consciousness. Neurological disorders also include epilepsy, Alzheimer disease and other dementias, cerebrovascular diseases including stroke, migraine and other headache disorders, multiple sclerosis, Parkinson's disease, neuron infections, brain tumours, traumatic disorders. Neurological disorders treated within the specialties of neurology and clinical neuropsychology.

6th International Conference on Vascular Dementia ,February 27th - March 01st, 2017 Amsterdam, Netherlands; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 14th Nanomedicine and Pharmaceutical Nanotechnology Conferences, April 09-11, 2018, Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology, March 17-20, 2016 Lisbon, Portugal. 10th International Conference on Neuroscience and Neuro Chemistry, February 27-28, 2017 Amsterdam, Netherlands

Related Societies:

Finnish Neurological Association, Georgian Society of Neurologists, Maryland Pharmacists Association, Turkish Pharmacists Association, German Society of Neurology, Italian Society for Pharmaceutical Sciences (SISF), Slovak Neurological Society, Swedish Neurological Society, European Academy of Neurology, European Paediatric Neurology Society, Utah Pharmaceutical Association, European Behavioural Pharmacology Society (EBPS), Italian Society of Neurology, World Federation of Neurology

Track 15: Neurology Treatments

Neurology treatments are used to treat neurological disorders. Blood tests can also be used to detect infections in the brain and spinal cord, bone marrow disease, damage to the blood vessels and toxins that affect the nervous system. Genetic testing of DNA from white cells in the blood can be used to diagnose congenital nervous disorders. Finally, the fluid that surrounds the brain and spinal cord can be analyzed to detect acute and chronic inflammation, meningitis and some rare infections. There are several key treatments for neurological disorders. Brain mapping is often used for brain tumors and epilepsy while brain stimulation is used for Parkinson’s disease. Neurosurgeons use three-dimensional imaging technology to operate on the brain so as to better target the precise area where a tumor is located and not produce any permanent neurological deficit. Deep brain stimulation uses battery-operated neurotransmitters implanted under the collarbone to prevent the abnormal brain signals that are produced in patients with Parkinson’s disease.

Related Societies:

Track 16: Computational Neuroscience/modeling

Computional Neuroscience is a science that links the miscellaneous fields of neuroscience, cognitive science, and psychology with electrical engineering, computer science, mathematics, and physics. It is altered from psychological connectionism and from learning theories of disciplines, like machine learning, neural networks, and computational learning theory in that it emphasizes descriptions of functional and biologically realistic neurons and their physiology and dynamics. Computational models deals with the study of brain function in terms of the information processing properties of the structures that make up the nervous system. The Computational models are used in frame hypotheses that can be directly tested by psychological or biological experiments.

The University of Queensland, Brisbane , Australia. Dec. 13 - 15, 2017; Computational and Systems Neuroscience, Denver & Breckenridge, Colorado. Mar. 1 - 6, 2018, Systems & Computational Neuroscience Down Under, Queensland Brain Institute, Twenty Seventh Annual Computational Neuroscience Meeting UW & Allen Institute, Seattle, Washington. Jul. 13 - 18,2018 , Research in Encoding And Decoding of Neural Ensembles, Nomikos Conference Centre, Santorini, Greece. Jun. 20 - 24, 2018.

Related Societies:

Utah Pharmaceutical Association, Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Belgian Society of Pharmaceutical Sciences, The Pharmaceutical Society of Australia, Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association

Track 17: Advance Research in Neuropharmacology

Neuropharmacology is an emerging field of science, rising exponentially with the understanding of nervous system and its related disorders, drugs and treatments. The major area of research includes mechanisms of novel drugs, neuro stem cell therapy, immunoglobulin therapy, gene therapy in neuronal disorders and neural engineering. The global market for medical imaging systems is estimated to be $17 billion in 2009 and is forecast to grow at a compound annual growth rate (CAGR) of 5.8% from 2009 to 2014. Ultrasound systems comprise 29% of the global medical imaging systems market. X-ray systems are next, with a 24% share. Positron emission tomography has seen growth but it is the smallest segment. The X-ray market is growing well due to the introduction of digital technology.

3rd International Conference on Dual Diagnosis & Addiction Therapy, June 14-16, 2018 Amsterdam, Netherlands; 10th International Conference on Vascular Dementia, February 22-23, 2018 Paris, France; 18th Global Neurologists Annual Meeting on Neurology and Neurosurgery Conference, Nov 13-15, 2017, Athens, Greece; 10th International Conference on Neuroscience and Neuro Chemistry February 27-28, 2017 Amsterdam, Netherlands; 21st World Congress on Controversies in Neurology March 17-20, 2016 Lisbon, Portugal

Related Societies:

Kuwait Pharmaceutical Association, Maryland Pharmacists Association, Turkish Pharmacists Association, Utah Pharmaceutical Association, Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), The Pharmaceutical Society of Australia, European Behavioural Pharmacology Society (EBPS),Belgian Society of Pharmaceutical Sciences, European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF)

Market Analysis

Neuropharmacology 2018 welcomes attendees, presenters, and exhibitors from all over the world to Paris, France. We are delighted to invite you all to attend and register for the “10th World Congress on Neuropharmacology”(Euro Neuropharmacology-2018) which is going to be held during August 28-29, 2018 Paris, France. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Euro Neuropharmacology-2018, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Euro Neuro Pharmacology-2018 organizing committee look forward to meet you at Paris, France.

For more details please click - https://neuro.pharmaceuticalconferences.com/europe/

Global market

The French pharmaceutical market is forecast to grow at a "tepid" CAGR of 0.7% from $46.2 billion in 2014 to $48.2 billion by 2020, according to a report from research and consulting firm Global Data.

The volume of generic drug market increased from 23.6% in 2009 to 36.3% in 2016. The medical device market was valued at $18.2 billion in 2016 and is projected to grow at a CAGR of 4% to $22.5 billion by 2021.

France was a relatively late entrant to the generics market compared to the UK and Germany. The report highlights that, in 2008, generic drugs accounted for only 21.7% of France's pharmaceutical market in terms of volume. This figure had increased to 30.2% by 2013.

Joshua Owide, Global Data’s Director of Healthcare Industry Dynamics, commented: “While patented drugs dominate France’s pharmaceutical market, the volume of prescribing attributed to generic drugs will shift closer to levels seen in the rest of Europe, restricting French market growth. However, Owide adds, a number of factors, including an aging population, tax incentives, a substantial skilled workforce and high public healthcare expenditure, will serve to boost France's pharma market. “Additionally, numerous incentives, such as the abolition of corporate tax and the Research Tax Credit to support research and development, are enhancing the competitiveness of healthcare enterprises and will help to sustain the pharmaceutical market.”

France is the second largest drug market in Europe with annual sales topping €36bn. Pharma remains a crucial sector for the economy and the fourth most important contributor to the nation's trade surplus. France is second in R&D investment, with a combined budget of around €5bn per year. France has a network of innovative companies operating across the drug value chain, in research, development, production and marketing. Vaccines, generics and consumer health are its strongest units and make up a crucial part of its diversification strategy. According to the company's projections, about 40 per cent of its profits by 2015 could come from 'pharmerging' markets as conditions worsen in Europe and the US. France wants to remain a key global player as medicine undergoes the revolution of personalization in wealthy, industrialized nation as patient care evolves and as the health industry professions converge to provide comprehensive management of diseases.

Scope of Neuropharmacology

Current Neuropharmacology provides current, timely and comprehensive reviews and guest edited issues of all areas of neuropharmacology and related matters of neuroscience. The reviews cover the fields of molecular, cellular, and systems/behavioral aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Neuropharmacology is the study of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behavior. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

Neuroscience: Neuroscience include intercellular signaling, intracellular signaling, cell injury and inflammation, neurodegenerative diseases, sensory transduction, neural processing, Gene regulation & genetics, Brain development & Cell differentiation, Bioenergetics & Metabolism, Neuronal plasticity & behavior, Molecular basis of disease etc.

Importance of Neuropharmacology

Neuropharmacology is a very broad region of science that encompasses many aspects of the nervous system from single neuron manipulation to entire areas of the brain, spinal cord, and peripheral nerves. To better understand the basis behind drug development, one must first understand how neurons communicate with one another. This article will focus on both behavioral and molecular neuropharmacology; the major receptors, ion channels, and neurotransmitters manipulated through drug action and how people with a neurological disorder benefit from this drug action. It is necessary to focus on neuropharmacology and the use of neuropharmaceuticals to transform brain processes in the way of enhancing memory, mood, sensation, thinking and attention in people.

Why to attend???

Neurology and Therapeutics is a unique forum to bring together worldwide distinguished academics in the field of neuroscience and neurology, Brain researchers, public health professionals, scientists, academic scientists, industry researchers, scholars to exchange about state of the art research and technologies. Aim of this conference is stimulate new ideas for treatment that will be beneficial across the spectrum of Brain disorders.

A Unique Opportunity for Advertisers and Sponsors at this International event:

https://neuro.pharmaceuticalconferences.com/europe/

Conference Highlight

Neuropharmacology
Neurology
Pediatric Neurology
Neurobiochemistry
Nursing and Neuroscience
Neural Stem Cells
Neuro- AIDS
Neurovirology
Neurosurgery
Neuroradiology
Clinical Neuropharmacology
Molecular Neuropharmacology
Biochemical Neuropharmacology
Behavioral Neurology
Psychopharmacology and Immunopharmacology
Neurological disorders
Neurology Treatments
Computational Neuroscience/modeling
Advance Research in Neuropharmacology

Around 50 associations of Neurology are there in France:

Alzheimer’s Association
Stroke Association
National Association for Mental Health
National Neurological Member Societies
Alzheimer’s and Dementia Societies in France
National Brain Tumor organization
National Neurological Member Societies

Target Audience:

Neurologist
Neuroscientist
Neuroscientist
Professors
Directors
Head of Department
Neurosurgeons
Psychiatrist
Nutritional Scientists\Students from Academia in the research of Neurology, Nutrition

Around 500 Universities globally working in the field of Neuropharmacology:

University of Oxford
New York University
McGill University
King's College London
Harvard University
University of California--Los Angeles
Columbia University
University of Cambridge
University College London
University of California--San Francisco
Stanford University
Claud Bernard University Lyon 1
Washington University in St. Louis
Université Paris-Sud
University of Montpellier
University of Strasbourg

Neuropharmacology Universities in Paris:

Pierre and Marie Curie University
Paris Dauphine University
University of Lyon
Paris-Sorbonne University
Paris Descartes University-Paris V
Paris Descartes Superieure
Paris University Paris Diderot-Paris 7

Top Hospitals Associated with Neuropharmacology Research in World

UNM Neurology Centre
Jefferson Hospital for NeuroscienceHuntington Hospital
Massachusetts General Hospital
Tampa General Hospital
Mayo Clinic
EI Camino Hospital
John Hopkins Medicine
EI Camino Hospital

Top Hospitals Associated with Neuropharmacology in Paris:

Hôpital Bichat Claude-Bernard
Hôpital Americain de Paris
Hôpital de la Pitié-Salpetrière
Hôpital Necker-Enfants Malades
Hôpital Européen Georges-Pompidou
Hôpital Saint-Antoine

Companies Associated with neuropharmacology Research in World are:

Pfizer
Eisai
Biogen Idec
Novartis
Otsuka
Johnson & Johnson
Teva
Lilly
Merck KGaA
AstraZeneca
Bristol-Myers Squibb
Lundbeck
GlaxoSmithKline
Bayer

Conference Series llc Ltd takes a great honor in announcing the commencement of 10th World Congress on Neuropharmacology August 28-29, 2018 Paris, France. Neurology-2017 has received a benevolent response from all over the world. This has been conducted with the aim and the categorical intent of promoting the developments of new perceptions and ideas for exploring the high level of knowledge reached by scientific community on Neuroscience. The extremely illustrious conference hosted by ConferenceSeries was marked with the attendance of young and brilliant researchers, clinicians, business delegates and talented student communities.

The conference was organized around the theme Scientific quest to enhance the fascinating and mystified Neurons. The event implanted a firm relation of upcoming strategies in the field of Neurology with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

This annual conference brought together eminent scientists, Neurologist, Neuroscience researchers, health care professionals, University professors, Neuroscience professionals in which many issues in Neuroscience research were discussed in depth to provide up-to-date information to the world. On the other hand, the meeting provided an opportunity for an open and animated sharing of ideas and experiences.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of Neuroscience. The eminent personalities at the conference were Joel Schachter ,Merck Research Laboratories ,USA, Juan Camilo Urazan, Universidad Manuela Beltran ,Colombia, Mariya Hristova, University College London ,UK, John Varghese, University of California ,USA, Harish Pant, National Institutes of Health, USA

ConferenceSeries offers its heartfelt appreciation to all the Organizing Committee Members, Chairs and Co-Chairs, Speakers, Students, Media Partners and Editorial Board Members of Journal of Neurology & Neurophysiology, Journal of Neuroinfectious Diseases and Journal of Neurological Disorders who supported the conference in every aspect for the awe-inspiring exhibition at the venue.

We once again thank you all for the enormous exquisite response. This inspires us to continue organizing events and conferences for furthering the Neuroscience Research. ConferenceSeries therefore, is glad to announce its 10th World Congress on Neuropharmacology August 28-29, 2018 Paris, France

Mark your calendars for the upcoming meeting; we are hoping to see you soon!

Let us meet again @ Euro Neuropharmacology 2018

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	August 28-29, 2018
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed	Day 1
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

10th World Congress on Neuropharmacology August 28-29, 2018 Paris, France

Recommended Global Pharmaceutical Sciences Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

Euro Neuropharmacology 2018

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues